Cancer Research  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 4540-4543, October 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nichols, K. E.
Right arrow Articles by Haber, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nichols, K. E.
Right arrow Articles by Haber, D. A.

WT1 Induces Expression of Insulin-like Growth Factor 2 in Wilms' Tumor Cells1

Kim E. Nichols, Gian G. Re, Yu Xin Yan, A. Julian Garvin and Daniel A. Haber2

Laboratory of Molecular Genetics, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts 02129 [K. E. N., Y. X. Y., D. A. H.], and Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina [G. G. R., A. J. G.]

The Wilms' tumor suppressor gene WT1 encodes a zinc finger transcription factor, whose expression inhibits the growth of the RM1 Wilms' tumor cell line. Transient transfection of WT1 constructs into 3T3 or 293 cells results in transcriptional repression of a number of cotransfected promoters containing the early growth response gene 1 consensus sequence. We now show that WT1 has properties of a transcriptional activator in RM1 cells, an effect that may be associated with the presence of a mutated p53 gene in these cells. Stable transfection of wild-type WT1 into RM1 cells results in induction of endogenous insulin-like growth factor 2 (IGF2) but not of other previously postulated WT1-target genes. The induction of IGF2 is dramatically enhanced by WT1 mutants encoding an altered transactivation domain. We conclude that IGF2 is a potentially physiological target gene for WT1 and that its induction may contribute to the growth-stimulating effects of WT1 variants.

1 This grant was supported by NIH Grants CA 37887 (to A. J. G.) and CA 58596 (to D. A. H.).

2 To whom requests for reprints should be addressed, at Massachusetts General Hospital Cancer Center, CNY 7, Building 149, 13th Street, Charlestown, MA 02129. Phone: (617) 726-7805; Fax: (617) 726-5637.

Received 7/ 6/95. Accepted 8/30/95.




This article has been cited by other articles:


Home page
Microbiol. Mol. Biol. Rev.Home page
G. M. Santangelo
Glucose Signaling in Saccharomyces cerevisiae
Microbiol. Mol. Biol. Rev., March 1, 2006; 70(1): 253 - 282.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Hosono, I. Gross, M. A. English, K. M. Hajra, E. R. Fearon, and J. D. Licht
E-cadherin Is a WT1 Target Gene
J. Biol. Chem., April 6, 2000; 275(15): 10943 - 10953.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L.-S. Guan, M. Rauchman, and Z.-Y. Wang
Induction of Rb-associated Protein (RbAp46) by Wilms' Tumor Suppressor WT1 Mediates Growth Inhibition
J. Biol. Chem., October 16, 1998; 273(42): 27047 - 27050.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.